G. M. Andrade, R. da S. Ferreira, M. V. Milki, and S. R. de O. Crispim, “Capivasertib and fulvestrant, a new salvation for hormone receptor-positive breast cancer? A systematic review”, MAST, vol. 34, no. suppl. 1, Mar. 2026.